Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 19, 1995 - Issue 3-4
20
Views
6
CrossRef citations to date
0
Altmetric
Original Article

HB Hakkari or α2β231(B13)LEU→ARG, A Severely Unstable Hemoglobin Variant Associated with Numerous Intra-Erythroblastic Inclusions and Erythroid Hyperplasia of the Bone Marrow

, , , , , & show all
Pages 165-172 | Received 03 Oct 1994, Accepted 03 Mar 1995, Published online: 07 Jul 2009
 

Abstract

A severely unstable hemoglobin variant, Hb Hakkari or α2β231 (B13)Leu→Arg, has been observed in a 5-year-old Turkish girl with a severe hemolytic anemia without Heinz body formation. A modest increase in liver and spleen size was present and the level of Hb F was a high 33%. The variant could not be observed in red cells and was only detected through sequencing of the amplified β-globin gene and also by hybridization with specific oligonucleotide probes. The parents were normal, and it is assumed that the variant occurred as a de novo mutation. Smears from bone marrow aspirates showed numerous inclusion bodies in the erythroblast and, as a result, a erythroid hyperplasia. It is suggested that the hemoglobin variant which is unstable and is readily losing its heme group because one of the heme binding sites has been lost, precipitates in the erythroblasts, thus interfering with the maturation process and causing the severe anemia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.